BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34298212)

  • 21. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
    Jung JG; Ahn SH; Lee S; Kim EK; Ryu JM; Park S; Lim W; Jung YS; Chung IY; Jeong J; Chang JH; Shin KH; Chang JM; Moon WK; Han W
    BMC Cancer; 2022 Feb; 22(1):189. PubMed ID: 35184724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?
    Kantor O; Pesce C; Liederbach E; Wang CH; Winchester DJ; Yao K
    Breast J; 2017 Sep; 23(5):554-562. PubMed ID: 28295828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
    Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
    Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ
    Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
    Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
    Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
    Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
    Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.
    Wang Z; Wu LC; Chen JQ
    Breast Cancer Res Treat; 2011 Oct; 129(3):675-89. PubMed ID: 21743996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.
    Burak WE; Hollenbeck ST; Zervos EE; Hock KL; Kemp LC; Young DC
    Am J Surg; 2002 Jan; 183(1):23-7. PubMed ID: 11869698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
    Parks RM; Cheung KL
    Breast; 2017 Jun; 33():57-70. PubMed ID: 28282588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
    Cohen BL; Collier AL; Kelly KN; Goel N; Kesmodel SB; Yakoub D; Moller M; Avisar E; Franceschi D; Macedo FI
    Ann Surg Oncol; 2020 Jun; 27(6):1830-1841. PubMed ID: 31989360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.
    Biglia N; Bounous VE; Gallo M; Fuso L; Sgro LG; Maggiorotto F; Ponzone R
    Breast; 2018 Oct; 41():8-13. PubMed ID: 29933180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary lymph node dissection for patients with invasive breast cancer at Charlotte Maxeke and Chris Hani Baragwanath Academic Hospitals.
    Groenewald C; Cubasch H; Mannell A; Ayeni O; Nietz S
    S Afr J Surg; 2019 Dec; 57(4):18-24. PubMed ID: 31773927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
    Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
    Breast Cancer Res Treat; 2017 May; 163(1):93-101. PubMed ID: 28213781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
    ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary Dissection
    Arisio R; Borella F; Porpiglia M; Durando A; Bellino R; Bau MG; DE Sanctis C; Danese S; Benedetto C; Katsaros D
    In Vivo; 2019; 33(6):1941-1947. PubMed ID: 31662523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.